Background: Triglyceride glucose index (TyG index) is a novel marker of insulin resistance. Studies have shown that TyG index is closely associated with the occurrence of hypertension and cardiovascular disease. However, little is known about the correlation between TyG index and the occurrence of heart failure with preserved ejection fraction (HFpEF) in hypertensive patients. Hypothesis: Our study assumes that TyG index strongly correlates with occurence of HFpEF in hypertensive patients. Methods: This research enrolled 559 hypertensive patients (273 patients with HFpEF and 286 without HFpEF) admitted to the Department of Cardiology of Jiading Branch of Shanghai General Hospital from 2020 to 2021 as the study subjects. Gender, age, diastolic blood pressure, systolic blood pressure (SBP), and heart rate (HR) were recorded at admission. Medication history and fasting blood samples were harvested after admission to detect laboratory index. Cardiac function and ventricular structure index were measured by echocardiography. Pearson correlation analysis was conducted to identify the correlation of TyG index with cardiac function and ventricular structure. The receiver operating characteristic (ROC) curve was used to evaluate the diagnostic value of TyG index in HFpEF with hypertension.Results: HFpEF patients had higher diuretic use frequencies, fasting plasma glucose, NT-proBNP, triglycerides, TyG index, left atrial diameter (LAD), left ventricular mass index (LVMI), the ratio of peak E-velocity of mitral orifice to peak velocity of early diastolic mitral annulus (E/e′), and SBP but lower ratio of peak E of early diastolic maximum blood flow velocity to peak A of late diastolic maximum blood flow velocity of mitral orifice (E/A) and average e′ than non-HFpEF patients. Moreover, TyG index was correlated with LAD, left ventricular ejection fraction (LVEF), LVMI, average e′, E/e′, and NT-proBNP. The multivariate regression analysis suggested that TyG index, E/e′, and NT-proBNP were independent risk factors for HFpEF in
Background As a novel marker of insulin resistance, the ratio of triglyceride/high-density lipoprotein cholesterol (TG/HDL-C) has been recently reported to be related to the occurrence of coronary artery diseases. However, no research has been conducted to probe whether the TG/HDL-C ratio is associated with the occurrence of coronary microvascular disease (CMVD). Aim This study investigates the association between the TG/HDL-C ratio and the occurrence of CMVD. Methods This study included 175 patients diagnosed with CMVD in the Department of Cardiology of our hospital from October 2017 to October 2021 as the study group and 175 patients with no chest pain, no history of cardiovascular disease and drug use, and negative results of exercise treadmill testing as the non-CMVD group. The clinical data of the two groups were compared. In addition, the risk factors of CMVD were analyzed with logistic regression, and the efficacy of independent risk factors in predicting CMVD was analyzed with a receiver operating characteristic (ROC) curve. Results Compared with those in the non-CMVD group, the proportion of females, the incidence of hypertension and type 2 diabetes, the level of platelet count, TG, and C-reactive protein, and the ratio of TG/HDL-C were increased in the CMVD group, accompanied by decreased levels of albumin and HDL-C (P < 0.05). Logistic regression results revealed C-reactive protein (the area under the ROC curve [AUC] value: 0.754; 95% confidence interval [CI]: 0.681–0.827), sex (the AUC value: 0.651; 95%CI: 0.571–0.730), albumin (the AUC value: 0.722; 95%CI: 0.649–0.794), and TG/HDL-C ratio (the AUC value: 0.789; 95%CI: 0.718–0.859) as the independent risk factors of CMVD. Conclusion The TG/HDL-C ratio is an independent risk factor for the occurrence of CMVD.
Background: Triglyceride/high-density lipoprotein (TG/HDL-C) is a novel marker of insulin resistance. Recently, it has been documented that this index is related to the occurrence of coronary artery diseases. However, no research has reported whether TG/HDL-C is associated with the occurrence of coronary microvascular disease (CMVD). Aim: This study set out to investigate the association betweentriglyceride/high-density lipoprotein cholesterol ratio(TG/HDL-C) and occurrence of coronary microvascular disease(CMVD). Methods: 175 patients with CMVD diagnosed in the department of cardiology in our hospital from October 2017 to October 2021 were selected as the study group and 175 patients without chest pain and history of cardiovascular disease who underwent physical examination in the medical examination center of our hospital were selected as the non-CMVD group. The clinical data were compared between the two groups. The risk factors of CMVD were analyzed using logistic regression, and the efficacy of independent risk factors in predicting CMVD was analyzed by a receiver operating characteristic (ROC) curve. Results: Compared with healthy group, the proportion of female, hypertension, type 2 diabetes, platelet count, total cholesterol, C-reactive protein and triglyceride/high-density lipoprotein ratio were increased in CMVD group (P < 0.05), but albumin level and high-density lipoprotein cholesterol were decreased (P < 0.05). Logistic regression analysis suggested that C-reactive protein, female, albumin and triglyceride/high-density lipoprotein were independent risk factors for CMVD, with the area under the curve of 0.754, 0.651, 0.722 and 0.789 the 95% confidence interval of (0.681-0.827), (0.571-0.730), (0.649-0.794) and (0.718-0.859) (P< 0.001), respectively. Conclusion: Triglyceride/high-density lipoprotein(TG/HDL-C) is an independent risk factor for occurrence of CMVD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.